| Name | RTW Biotech Opportunities Ltd |
|---|---|
| Epic | RTWG |
| Isin | GG00BKTRRM22 |
| Industry |
| Latest share price | 116.00p | Net gearing | n/a |
|---|---|---|---|
| Market capitalisation | £241.72 | Debt ratio | n/a |
| Shares in issue | 208.38 | Debt-to-equity ratio | n/a |
| P/E ratio | n/a | Assets / equity ratio | n/a |
| Total dividends per share | n/a | Price to book value | n/a |
| Dividend yield | n/a | ROCE | n/a |
| Dividend cover | n/a | EPS growth | n/a |
| Earning per share | -2.26 | 52-week high / low | 89.10p / 133.00p |
| Type | Ex-date | Pay-date | Net-dividend |
|---|---|---|---|
| No dividends declared | |||
| Company name | RTW Biotech Opportunities Ltd |
|---|---|
| Address | 1st Floor, Royal Chambers, St Julian's Avenue, St Peter Port, Guernsey, United Kingdom, GY1 3JX |
| Telephone | |
| Website | http://www.rtwfunds.com/ |
| Director | Position |
|---|---|
| Mr William (Bill) Simpson | Chairman |
| Ms Stephanie Sirota | Non-Executive Director |
| Mr William Scott | Independent Non-Executive Director |
| Mr Paul Le Page | Independent Non-Executive Director |
| Assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Reporting date | 31/12/23 | 31/12/22 | 31/12/21 |
| Intangible asssets and goodwill | n/a | n/a | n/a |
| Investments and other non-current assets | 367.61 | 350.13 | 409.18 |
| Total non-current assets | 367.61 | 350.13 | 409.18 |
| Inventory / work in progress | n/a | n/a | n/a |
| Trade and other receivables | n/a | n/a | n/a |
| Cash and equivalents | 2.72 | 6.97 | 6.48 |
| Other current assets and asset held for resale | n/a | n/a | n/a |
| Total of all assets | 446.23 | 401.54 | 439.36 |
| Liabilities $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Short term liabilities | n/a | n/a | n/a |
| Long term liabilities | n/a | n/a | n/a |
| Other liabilites / pension etc | 17.21 | 53.62 | 52 |
| Total of all liabilities | 17.21 | 53.62 | 52 |
| Net assets $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net assets | 429.02 | 347.92 | 387.36 |
| Equity $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Share capital | n/a | n/a | n/a |
| Minority interests | n/a | n/a | n/a |
| Retained earnings | n/a | n/a | n/a |
| Share premium account | n/a | n/a | n/a |
| Total equity | 429.02 | 347.92 | 387.36 |
| Income $ (m) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Turnover | n/a | n/a | n/a |
| Operating profit | -3.2 | -4.51 | -7.8 |
| Pre-tax profit | -4.76 | -5.29 | -7.8 |